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previous study used bone-marrow chime-
ric mice in which there was a 1:1 mixture
of wild-type DCs and Myd88/ DCs.
Given that TLR-stimulated DCs seem to
be the chief source of IL-12 and other
proinflammatory cytokines, it is possible
ablation of TLR signaling in the vast ma-
jority of DCs compromises both the direct
and indirect pathway of DC activation.
The observations in this study reaffirm
some old truths and reveal new ones.
The paradigm that TLR-mediated activa-
tion of DCs is essential for orchestration
of innate and adaptive responses seems
to be true when soluble TLR ligands are
used. However, it does not seem to hold
true when particulated CpG is used, high-
lighting the fact that redundancy and con-
text recognition are two important facets
of the immune system.
In summary, the invention of Hou et al.
(2008) represents an important tool for
the dissection of the importance of the
role of TLR signaling in DCs. For example,
this mutant strain should be of great value
in understanding the role of TLRs in DCs in
sensing and tuning immune responses to
pathogens, commensals, and vaccines.
Thus, experiments that evaluate the in-
nate and adaptive responses to microbes,
viruses, commensals, and vaccines will
illuminate the importance of TLR signaling
in DCs in launching protective immunity
versus tolerance. Furthermore, the ques-
tion of what role TLR signaling in DCs
play in modulating the strength, quality,
and longevity of immune responses and
immunological memory is one of great
importance and deserves to be tested.
Thus, the invention of this tool, like the
one invented by our ancestor in 2001:
A Space Odyssey, will have great utility
in exploring deep and fundamental ques-
tions about our immunological universe.
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TNF clearly contributes to immunity to intracellular pathogens, but how it does so is incompletely under-
stood. In this issue of Immunity, Clay et al. (2008) provide unique insights, using intravital microscopy and
the zebrafish-embryo model of tuberculosis.The functional complexity of tumor necro-
sis factor (TNF) has provided a formidable
challenge to defining its roles in immunity
and in human health and disease. TNF ex-
erts its action on multiple cell types and
plays a critical but incompletely charac-
terized role in immunity to intracellular
pathogens, including pathogenic myco-
bacteria. TNF contributes to control of
mycobacterial growth in vivo, as well as
to the immunopathology of tuberculosis.
The importance of delineating TNF’s
many roles is underscored by the obser-vations that TNF-neutralizing drugs can
promote progression of tuberculosis,
which can be fatal. Although these drugs
have revolutionized treatment of certain
diseases, their infectious complications
can be devastating. A clearer understand-
ing of how drugs that block TNF modulate
immunity to intracellular pathogens may
allow us to devise ways to minimize their
infectious complications and still retain
their anti-inflammatory benefits.
One way that TNF may promote control
of M. tuberculosis is through its effects onImmunity 2granulomas. Granulomas consist of orga-
nized aggregates of macrophages (and in
some cases, dendritic cells) that also re-
cruit B and T lymphocytes and provide
a local environment in which immune cells
interact to suppress the pathogen. The
unique organization of granulomas also
serves to prevent widespread inflamma-
tion. Evidence indicates that TNF plays
an essential role in both formation and
maintenance of granulomas, but the
mechanisms of these actions are poorly
understood. In this issue of Immunity,9, August 15, 2008 ª2008 Elsevier Inc. 175
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tions in granuloma formation and mainte-
nance by employing the Mycobacterium
marinum zebrafish-embryo model. In this
model, optically transparent embryos
allow visualization and investigation of
TNF’s roles in control of pathogen growth
and cell trafficking and fate in nascent
granulomas in the absence of adaptive
immunity. Some of their findings support
certain previous data, and they shed
new light on specific aspects of TNF-
granuloma interplay in mycobacterial
infections.
Is TNF necessary for granuloma forma-
tion? Because granulomas are defective
in mice that lack TNF activity, it is com-
monly believed that TNF orchestrates the
initial formation of granulomas in myco-
bacterial (BCG or virulent M. tuberculosis)
infections. In the absence of TNF signal-
ing, granulomas in various tissues are
present in markedly decreased numbers
(Kindler et al., 1989), are smaller (Zganiacz
et al., 2004), and lack cellular organization
and characteristic architecture (Flynn
et al., 1995). However, these studies
were limited by their having to sample tis-
sues at discrete time points after infection,
making it difficult to distinguish effects of
TNF on initial formation of granulomas
from effects on granuloma maintenance.
To circumvent this limitation, Clay et al.
(2008) utilized intravital imaging of zebra-
fish embryos to track the movement of
M. marinum-infected macrophages after
ablation of TNF signaling. Surprisingly,
animals that were deficient in TNF signal-
ing, termed TR1 morphants, had unim-
paired macrophage trafficking, acceler-
ated granuloma formation, and a small
increase in the number of granulomas
formed. In other words, in this system,
TNF signaling is not essential for the initial
events in granuloma formation: recruit-
ment of uninfected macrophages to the
site of initial infection and aggregation of
infected and uninfected macrophages.
In addition, the authors investigate
granuloma formation in TR1 morphants
infected with M. marinum lacking the
RD1 (also known as ESX1) locus, which
encodes a specialized secretion system
essential for virulence. In a previous report
using the zebrafish model, the RD1(ESX1)
locus was shown to be responsible for
causing aggregation of infected macro-
phages into granulomas, leading to inter-
cellular bacterial dissemination and in-176 Immunity 29, August 15, 2008 ª2008 Elscreased bacterial numbers (Volkman
et al., 2004). In the present study, Clay
et al. (2008) found that granuloma forma-
tion remains abnormal in TR1 morphants
infected with RD1-deficient M. marinum.
Because TNF has a major role in control-
ling replication of intracellular mycobacte-
ria (see below), it is possible that the in-
crease in mycobacterial replication seen
early on in TR1 morphants infected
with wild-type M. marinum accelerates
granuloma formation through a conse-
quent proportional increase in secretion
of RD1(ESX1) proteins.
Is TNF necessary for granuloma main-
tenance? Studies using mice chronically
infected with Mycobacterium tuberculosis
have found that neutralization of TNF
results in failure to maintain the granuloma
structure, resulting in diffuse cellular
infiltration of the lungs (Algood et al.,
2004; Chakravarty et al., 2008). In a recent
paper in Immunity, Egen et al. employed
intravital imaging in mice that had estab-
lished Mycobacterium bovis BCG granu-
lomas. Neutralization of TNF resulted in
marked reduction of granuloma size, due
to selective reduction of the number of un-
infected macrophages, with preservation
of the number of BCG-infected cells
(Egen et al., 2008). The time resolution of
those studies did not reveal whether the
reduction in the number of uninfected
cells was a consequence of accelerated
cell death or egress, of decreased cell
recruitment, or a combination of these.
The necessity for TNF signaling in the
maintenance of granulomas is substanti-
ated by the findings in the present study.
Although granulomas formed in an accel-
erated fashion after M. marinum infection,
they subsequently became larger but
contained more dead macrophages in
the absence of TNF signaling.
What mechanisms underlie TNF’s role
in granuloma maintenance? Although
abundant data indicate that TNF is re-
quired for maintenance of granulomas, it
is less clear how it accomplishes this ef-
fect. Maintenance of granuloma structure
is likely to be dependent upon cell viabil-
ity, cell-adhesion proteins, chemokine
gradients, and chemokine-receptor ex-
pression; each of these could be regu-
lated by TNF (see Figure 1). In the murine
model, neutralization of TNF in vitro and
in vivo leads to decreased secretion of
chemokines by infected macrophages
and other CD11b+ cells, and such aevier Inc.decrease may result in disruption of cell
migration into and out of granulomas (Al-
good et al., 2004). Moreover, other work
has revealed a regulatory role of TNF on
IFN-g-producing CD4+ and CD8+ T cells
in BCG-infected mice, in which TNF pre-
vents T cell-dependent granuloma disin-
tegration and inflammatory destruction
of the lung tissue (Zganiacz et al., 2004).
Additional work has focused on the
roles of TNF in regulating cell death by ap-
optosis and necrosis within granulomas,
with variable results. Large numbers of
apoptotic macrophages and/or lympho-
cytes were observed in murine studies in
which TNF blockade resulted in major his-
topathologic deterioration of lung tissue
(Mohan et al., 2001; Zganiacz et al.,
2004). This is in contrast to the findings
that TNF induces apoptosis of human
alveolar macrophages infected with
M. tuberculosis in vitro (Keane et al.,
2002). Furthermore, it remains to be de-
termined whether apoptosis reduces bac-
terial numbers in vivo or has other benefits
such as increasing crosspresentation by
dendritic cells. In the study by Clay et al.
(2008), increased cell death in granuloma
macrophages occurred in the absence
of TNF signaling, but assays for apoptosis
revealed no differences between TR1
morphants and controls. The authors
conclude that granuloma macrophages
undergo death by necrosis or a related
pathway in the absence of TNF signaling,
resulting in release of viable bacteria
that then spread to adjacent cells. Thus,
in this model, TNF signaling promoted
survival of macrophages within the granu-
loma, perhaps by a primary mechanism
of restricting replication of virulent myco-
bacteria, in order to prevent further
spread of infection.
Does TNF regulate intracellular killing of
mycobacteria in granulomas? Murine
studies reveal variable increases in bacil-
lary load when TNF is neutralized, ranging
from small changes to multiple orders of
magnitude (Flynn et al., 1995; Kindler
et al., 1989; Zganiacz et al., 2004). In the
current study, the absence of TNF signal-
ing exerted an early effect on growth of
M. marinum in macrophages in vivo and
resulted in 10-fold enhancement of
intracellular replication. Considering the
evidence that the mycobacteria are the
primary driving force for granuloma induc-
tion (Volkman et al., 2004), control of bac-
terial growth and gene expression may
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on granuloma maintenance, with differ-
ences in cell viability and trafficking
as secondary events. Multiple studies,
including this report, have failed to dem-
onstrate induction of reactive nitrogen
intermediates as a mechanism for TNF-
dependent antimycobacterial activity,
thus, downstream mediators of this effect
remain to be identified (Flynn et al., 1995).
The results of studies in humans, mice,
and zebrafish have revealed considerable
insight into the formation and dynamics of
granuloma formation and maintenance
and into the essential contributions of
TNF to these immunological processes
(see Figure 1). The insights gained by the
studies of Egen et al. (2008) and of Clay
et al. (2008) are unprecedented, and the
techniques of intravital microscopy and
time-lapse video hold promise for produc-
ing further insight into the recruitment and
egress of infected and uninfected macro-
phages and dendritic cells and their inter-
actions with antigen-specific lympho-
cytes during distinct stages of infection.
Future work should focus on defining
both host and pathogen-specific molecu-
lar events and determinants of initiation
and maintenance of granulomas. Al-
though it seems logical that chemokines
and cell-adhesion molecules should be
crucial, identification and characterization
of the proximal molecules and their mech-
anisms, as well as regulation and the pre-
cise roles of TNF in these processes, re-
main an unsolved problem. Although the
RD1(ESX1) locus in virulent mycobacteria
Figure 1. TNF Action in Granuloma Dynamics and Immunity to Pathogenic Mycobacteria
As shown on the left, in the presence of optimal TNF signaling, macrophages and dendritic cells containing
mycobacteria form aggregates with uninfected cells and with CD4+ and CD8+ T lymphocytes and B lym-
phocytes and prevent progressive replication of bacteria. As shown on the right, blockade of TNF signaling
may have multiple effects on maintenance of granulomas: (1) Such a blockade may increase mycobacte-
rial replication and alter bacterial gene expression, with increased nonapoptotic death and intercellular
spread of bacteria (top); (2) decreased chemokine, chemokine-receptor, and/or adhesion-protein expres-
sion may decrease recruitment or increase egress of lymphocytes, macrophages, and dendritic cells
(middle); and (3) increased T cell apoptosis may cause altered host and bacterial gene expression and
increased bacterial replication and spread (bottom).Immunity 2plays a clear role in inducing granuloma
formation, the host targets of the ESX1-
secreted substrates have not yet been
identified, and the alternative mecha-
nisms used by mycobacteria to induce
granulomas (because ESX1-deficient
mycobacteria induce granulomas, albeit
with delayed kinetics) remain undefined.
Because neutralization of TNF can
profoundly disturb granuloma dynamics
before any increase in the number of bac-
teria can be detected (Chakravarty et al.,
2008), it is likely that mycobacteria them-
selves express distinct sets of genes and
host-interacting molecules in the pres-
ence and absence of TNF, and discovery
of the crucial mycobacterial genes and
their mechanisms of regulation and mo-
lecular interactions with the host should
be investigated.
By now, it should be clear that recent
studies have provided some illumination
of the black box of granulomas and the
multiple roles of TNF in optimizing their
defensive functions, but many more watts
will be necessary before we have a well-lit
view.
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